M O 5 (Oxybutynin chloride extended release 5 mg)
Pill imprint M O 5 has been identified as Oxybutynin chloride extended release 5 mg.
Oxybutynin is used in the treatment of overactive bladder; urinary incontinence; hyperhidrosis; dysuria; prostatitis and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Oxybutynin 5 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for M O 5
M O 5
- 5 mg
- 8.00 mm
- Rx and/or OTC
- Drug Class:
- Urinary antispasmodics
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|51079-0722||UDL Laboratories Inc|
|16590-0321||Stat RX USA LLC (repackager)|
Note: Inactive ingredients may vary.
More about oxybutynin
- Oxybutynin extended-release tablets
- Oxybutynin gel
- Oxybutynin syrup
- Oxybutynin system
- More (4) »
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.